Chemical Modification of Acetaminophen to Reduce Liver Toxicity and Enhance Drug Efficacy
JSHS · 2025
Overview
Acetaminophen is a widely used non-opioid analgesic and antipyretic medication. Unfortunately, its toxicity is a leading cause of liver transplantation worldwide. NAPQi, the toxic form of acetaminophen produced after oxidizing in the body, is an electrophi le that depletes glutathione and eventually attacks liver proteins, which are nucleophilic. Existing approaches to acetaminophen modification to decrease toxicity are impractical as they modify functional groups necessary for acetaminophen’s analgesic prop erties. Thus, this research aims to reduce toxicity without sacrificing the drug’s efficacy by modifying acetaminophen’s benzene ring structure. It was hypothesized that sequential transition metal catalysis, involving precise C -Hsilylation of acetaminophen, followed by the nucleophilic addition of an alkyne to the silicon center, could decrease acetaminophen toxicity while maintaining its therapeutic effectiveness. The lowest unoccupied molecular orbital (LUMO) energy values of acetaminophen analogues were computed through Orca 5.0 and retrieved in Avogadro to assess toxicity. Docking simulations were then performed through AutoDock Vina to analyze the efficacy of acetaminophen analogues by evaluating their binding to transient receptor potential vanilloid 1 (TRPV1). An original scheme was developed and optimized to synthesize 2 -phenylalkynylsilyl acetaminophen. All acetaminophen analogues had higher LUMO energies than the original compound, indicating reduced nucleophilic reactivity and decreased liver toxicity. They also exhibited enhanced binding to TRPV1, demonstrating improved analgesic efficacy. 2 -phenylalkynylsilyl acetaminophen was synthesized through precise C -Hsilylation via sequential transition metal catalysis, followed by nucleophilic addition of an alkyne. The research further suggests a previously unknown mechanism of transition metal catalyst chemoselectivity.
Competition history
- JSHS 2025
Resources
Related projects
ISEF · 2024
Chemical Modification of Acetaminophen to Decrease Liver Toxicity
ISEF · 2025
2-Phenylalkynylsilyl Acetaminophen as a Less Toxic and More Effective Pain Medication
ISEF · 2020
Acetaminophen Phenylbutyrate Conjugate Is an Alternate to Acetaminophen
ISEF · 2023
Modified Nanoporous Gold Sensor for the Electrochemical Detection of Acetaminophen
ISEF · 2022
Mitigating Impaired Drug Absorption To Shorten Medical Treatment and Enable Pharmaceutical Product Development: Critical Evaluation of Human Oral Bioavailability for Pharmaceutical Drug Paracetamol
ISEF · 2016
Next Generation Fatty Acid Binding Protein Inhibitors: Computer-Aided Drug Design and Synthesis of Novel Truxillic Acid Diesters for Chronic Pain Inhibition
ISEF · 2023
Molecular Modeling Guided Drug Design
ISEF · 2018
Novel Sustainable Process for Synthesis of Acetylsalicylic Acid: Application to Opioid Epidemic and CO2 Emissions
Closest projects by meaning, across every fair and year in the corpus.